{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:48:48Z","timestamp":1791906528362,"version":"4.3.4"},"reference-count":78,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["18H02668"],"award-info":[{"award-number":["18H02668"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP26bm1123088"],"award-info":[{"award-number":["JP26bm1123088"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current therapies for autoimmune diseases rely largely on nonspecific immunosuppression, which can lead to adverse effects such as malignancy and severe infections. Regulatory T cell (Treg)-based therapies have therefore attracted attention as a more targeted approach, particularly in preventive or early-stage settings. However, their efficacy after disease onset, especially in chronic inflammation, remains poorly established. Furthermore, it remains unclear whether Treg therapy exerts uniform therapeutic effects across tissues within the same individual. Here, we demonstrate that Tregs retain therapeutic potential in chronic autoimmune inflammation, but their efficacy differs between tissues. Using a TCR-retrogenic mouse model, in which monoclonal autoreactive CD4+ T cells drive spontaneous chronic dermatitis and arthritis, polyclonal Treg administration effectively resolved chronic dermatitis but only limited disease progression in chronic arthritis. Despite these differences in outcomes, transferred Tregs were detected in local tissues and draining lymph nodes, suggesting that tissue-specific environments may underlie differential therapeutic responsiveness. To investigate the basis of this difference, we performed microarray and gene set variation analysis-based pathway analyses. Under untreated conditions, skin and joint tissues exhibited distinct baseline pathway activity patterns, with the skin showing higher activity of the Hippo signaling pathway, a growth-regulatory pathway, and the joints displaying stronger enrichment of inflammation-related pathways, including complement- and angiogenesis-associated pathways. Following Treg administration, skin\u2014but not joint\u2014tissue showed pathway modulation, including increased Wnt and decreased IL-17 signaling pathway activity, consistent with a more reparative environment. These findings indicate that distinct inflammatory environments underlie differential responsiveness to Treg therapy across tissues, highlighting their context-dependent therapeutic potential in chronic autoimmune inflammation.<\/jats:p>","DOI":"10.1093\/intimm\/dxag051","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:18:51Z","timestamp":1790425131000},"source":"Crossref","is-referenced-by-count":0,"title":["Regulatory T cells exhibit differential therapeutic effects across tissues during chronic autoimmune inflammation"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7510-7546","authenticated-orcid":false,"given":"Yuji","family":"Nishimura","sequence":"first","affiliation":[{"name":"Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3157-4168","authenticated-orcid":false,"given":"Yosuke","family":"Nagahata","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8507 ,","place":["Japan"]},{"name":"Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra) Department of Complexity of Life, , Barcelona 08003 ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiya","family":"Ohara","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8507 ,","place":["Japan"]},{"name":"The Hakubi Center for Advanced Research, Kyoto University , Sakyo-ku, Kyoto 606-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Shiga University of Medical Science , Shiga 520-2192 ,","place":["Japan"]},{"name":"Department of Medical Technology, School of Life and Environmental Science, Azabu University , Kanagawa 252-5201 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Agata","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Shiga University of Medical Science , Shiga 520-2192 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hirota","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8507 ,","place":["Japan"]},{"name":"Department of Immunology and Inflammation, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University , Sakyo-ku, Kyoto 606-8507 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026101311194915600_dxag051-B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026101311194915600_dxag051-B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026101311194915600_dxag051-B3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026101311194915600_dxag051-B4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/1346-8138.14604","article-title":"Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists","volume":"46","author":"Kohsaka","year":"2019","journal-title":"J Dermatol"},{"key":"2026101311194915600_dxag051-B5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00007890-197210000-00001","article-title":"Malignant tumors arising de novo in immunosuppressed organ transplant recipients","volume":"14","author":"Penn","year":"1972","journal-title":"Transplantation"},{"key":"2026101311194915600_dxag051-B6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"2026101311194915600_dxag051-B7","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"2026101311194915600_dxag051-B8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/art.1780250602","article-title":"A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death","volume":"25","author":"Rosner","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2026101311194915600_dxag051-B9","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15131","article-title":"Risk factors for initial and recurrent severe infections in first hospitalized patients with systemic lupus erythematosus: a retrospective study of a Chinese cohort","volume":"27","author":"Zhu","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"2026101311194915600_dxag051-B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","article-title":"Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study","volume":"83","author":"Baker","year":"1987","journal-title":"Am J Med"},{"key":"2026101311194915600_dxag051-B11","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1093\/rheumatology\/keaf167","article-title":"Rituximab vs cyclophosphamide for cancer risk in ANCA-associated vasculitis","volume":"64","author":"Mahajan","year":"2025","journal-title":"Rheumatology"},{"key":"2026101311194915600_dxag051-B12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/acr.24425","article-title":"Cancer risk in a large inception systemic lupus erythematosus cohort: effects of demographic characteristics, smoking, and medications","volume":"73","author":"Bernatsky","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026101311194915600_dxag051-B13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/jamadermatol.2022.3337","article-title":"Association between low-dose methotrexate exposure and melanoma: a systematic review and meta-analysis","volume":"158","author":"Yan","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2026101311194915600_dxag051-B14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1084\/jem.156.2.634","article-title":"Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates","volume":"156","author":"Volkman","year":"1982","journal-title":"J Exp Med"},{"key":"2026101311194915600_dxag051-B15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"2026101311194915600_dxag051-B16","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1172\/JCI138416","article-title":"Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"2026101311194915600_dxag051-B17","doi-asserted-by":"publisher","first-page":"28950","DOI":"10.1073\/pnas.2012495117","article-title":"A biomimetic five-module chimeric antigen receptor (5M CAR) designed to target and eliminate antigen-specific T cells","volume":"117","author":"Kobayashi","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101311194915600_dxag051-B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo0777","article-title":"Antigen-specific depletion of CD4+ T cells by CAR T cells reveals distinct roles of higher- and lower-affinity TCRs during autoimmunity","volume":"7","author":"Yi","year":"2022","journal-title":"Sci Immunol"},{"key":"2026101311194915600_dxag051-B19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"2026101311194915600_dxag051-B20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"2026101311194915600_dxag051-B21","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J Immunol"},{"key":"2026101311194915600_dxag051-B22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/eji.200839073","article-title":"Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg","volume":"39","author":"Stephens","year":"2009","journal-title":"Eur J Immunol"},{"key":"2026101311194915600_dxag051-B23","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro\u2013expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"2026101311194915600_dxag051-B24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1716","article-title":"Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models","volume":"14","author":"Yang","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026101311194915600_dxag051-B25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41590-021-01001-4","article-title":"Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity","volume":"22","author":"Hu","year":"2021","journal-title":"Nat Immunol"},{"key":"2026101311194915600_dxag051-B26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"key":"2026101311194915600_dxag051-B27","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw2707","article-title":"Conversion of antigen-specific effector\/memory T cells into Foxp3-expressing Treg cells by inhibition of CDK8\/19","volume":"4","author":"Akamatsu","year":"2019","journal-title":"Sci Immunol"},{"key":"2026101311194915600_dxag051-B28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adq9913","article-title":"Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris","volume":"17","author":"Mukai","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026101311194915600_dxag051-B29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr6049","article-title":"Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases","volume":"17","author":"Mikami","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026101311194915600_dxag051-B30","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1073\/pnas.1206803109","article-title":"Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis","volume":"109","author":"Van Herwijnen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101311194915600_dxag051-B31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1126\/science.1259077","article-title":"Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease","volume":"346","author":"Ito","year":"2014","journal-title":"Science"},{"key":"2026101311194915600_dxag051-B32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"2026101311194915600_dxag051-B33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.immuni.2018.04.009","article-title":"Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis","volume":"48","author":"Hirota","year":"2018","journal-title":"Immunity"},{"key":"2026101311194915600_dxag051-B34","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20092301","article-title":"Complement drives Th17 cell differentiation and triggers autoimmune arthritis","volume":"207","author":"Hashimoto","year":"2010","journal-title":"J Exp Med"},{"key":"2026101311194915600_dxag051-B35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"},{"key":"2026101311194915600_dxag051-B36","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Van Der Fits","year":"2009","journal-title":"J Immunol"},{"key":"2026101311194915600_dxag051-B37","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.4049\/jimmunol.167.2.1004","article-title":"IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis","volume":"167","author":"Lubberts","year":"2001","journal-title":"J Immunol"},{"key":"2026101311194915600_dxag051-B38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-\u03b3 synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2026101311194915600_dxag051-B39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026101311194915600_dxag051-B40","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti\u2013interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med"},{"key":"2026101311194915600_dxag051-B41","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"key":"2026101311194915600_dxag051-B42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa2102388","article-title":"Bimekizumab versus adalimumab in plaque psoriasis","volume":"385","author":"Warren","year":"2021","journal-title":"N Engl J Med"},{"key":"2026101311194915600_dxag051-B43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(22)02302-9","article-title":"Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)","volume":"401","author":"McInnes","year":"2023","journal-title":"Lancet"},{"key":"2026101311194915600_dxag051-B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2026101311194915600_dxag051-B45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nprot.2006.61","article-title":"Generation of T-cell receptor retrogenic mice","volume":"1","author":"Holst","year":"2006","journal-title":"Nat Protoc"},{"key":"2026101311194915600_dxag051-B46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000074903","article-title":"Gene expression analysis of atopic dermatitis-like skin lesions induced in NC\/Nga mice by Mite antigen stimulation under specific pathogen-free conditions","volume":"132","author":"Heishi","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"key":"2026101311194915600_dxag051-B47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/meth.2001.1261","article-title":"An overview of real-time quantitative PCR: applications to quantify cytokine gene expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"key":"2026101311194915600_dxag051-B48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/cyto.1998.0426","article-title":"QUANTIFICATION OF MURINE CYTOKINE mRNAs USING REAL TIME QUANTITATIVE REVERSE TRANSCRIPTASE PCR","volume":"11","author":"Overbergh","year":"1999","journal-title":"Cytokine"},{"key":"2026101311194915600_dxag051-B49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"2026101311194915600_dxag051-B50","author":"R Core Team"},{"key":"2026101311194915600_dxag051-B51","author":"Bengtsson"},{"key":"2026101311194915600_dxag051-B52","author":"Irizarry"},{"key":"2026101311194915600_dxag051-B53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2026101311194915600_dxag051-B54","author":"Bolstad"},{"key":"2026101311194915600_dxag051-B55","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"2026101311194915600_dxag051-B56","author":"Wickham"},{"key":"2026101311194915600_dxag051-B57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/bioinformatics\/btl609","article-title":"A distribution free summarization method for affymetrix GeneChip\u00ae arrays","volume":"23","author":"Chen","year":"2007","journal-title":"Bioinformatics"},{"key":"2026101311194915600_dxag051-B58","author":"Sayers"},{"key":"2026101311194915600_dxag051-B59","author":"Mark"},{"key":"2026101311194915600_dxag051-B60","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026101311194915600_dxag051-B61","author":"Tenenbaum"},{"key":"2026101311194915600_dxag051-B62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1521-4036(200001)42:1&lt;17::AID-BIMJ17&gt;3.0.CO;2-U","article-title":"The nonparametric Behrens-Fisher problem: asymptotic theory and a small-sample approximation","volume":"42","author":"Brunner","year":"2000","journal-title":"Biometrical Journal"},{"key":"2026101311194915600_dxag051-B63","author":"Ara"},{"key":"2026101311194915600_dxag051-B64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2026101311194915600_dxag051-B65","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/15476278.2015.1086052","article-title":"Wnt signaling induces epithelial differentiation during cutaneous wound healing","volume":"11","author":"Houschyar","year":"2015","journal-title":"Organogenesis"},{"key":"2026101311194915600_dxag051-B66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.615131","article-title":"Inflammation and Wnt signaling: target for immunomodulatory therapy?","volume":"8","author":"Jridi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026101311194915600_dxag051-B67","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41590-020-0721-6","article-title":"The commensal skin microbiota triggers type I IFN\u2013dependent innate repair responses in injured skin","volume":"21","author":"Di Domizio","year":"2020","journal-title":"Nat Immunol"},{"key":"2026101311194915600_dxag051-B68","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.chom.2021.03.003","article-title":"Bacteria induce skin regeneration via IL-1\u03b2 signaling","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"2026101311194915600_dxag051-B69","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.4049\/jimmunol.1000848","article-title":"Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function","volume":"185","author":"Tanaka","year":"2010","journal-title":"J Immunol"},{"key":"2026101311194915600_dxag051-B70","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1111\/febs.16449","article-title":"Emerging roles of the Hippo signaling pathway in modulating immune response and inflammation-driven tissue repair and remodeling","volume":"289","author":"Mia","year":"2022","journal-title":"FEBS J"},{"key":"2026101311194915600_dxag051-B71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026101311194915600_dxag051-B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113926","article-title":"The Hippo signaling pathway in development and regeneration","volume":"43","author":"Zhong","year":"2024","journal-title":"Cell Rep"},{"key":"2026101311194915600_dxag051-B73","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/jid.2013.339","article-title":"YAP and TAZ regulate skin wound healing","volume":"134","author":"Lee","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2026101311194915600_dxag051-B74","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","article-title":"The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts","volume":"54","author":"Fri\u0161\u010di\u0107","year":"2021","journal-title":"Immunity"},{"key":"2026101311194915600_dxag051-B75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/cei.12338","article-title":"Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model","volume":"177","author":"Andersson","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2026101311194915600_dxag051-B76","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.4049\/jimmunol.1403012","article-title":"A new approach for the treatment of arthritis in mice with a novel conjugate of an anti-C5aR1 antibody and C5 small interfering RNA","volume":"194","author":"Mehta","year":"2015","journal-title":"J Immunol"},{"key":"2026101311194915600_dxag051-B77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","article-title":"Apelin is a novel angiogenic factor in retinal endothelial cells","volume":"325","author":"Kasai","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2026101311194915600_dxag051-B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1747.1998.00262.x","article-title":"Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice","volume":"111","author":"Detmar","year":"1998","journal-title":"J Invest Dermatol"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intimm\/advance-article-pdf\/doi\/10.1093\/intimm\/dxag051\/71431409\/dxag051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/advance-article-pdf\/doi\/10.1093\/intimm\/dxag051\/71431409\/dxag051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:19:58Z","timestamp":1791904798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/advance-article\/doi\/10.1093\/intimm\/dxag051\/8840838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":78,"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxag051","relation":{},"ISSN":["1460-2377"],"issn-type":[{"value":"1460-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"dxag051"}}